how-to
Is Esketamine Treatment Covered by Insurance? 2026 Guide
Table of Contents
- Is Esketamine Treatment Covered by Insurance? The Short Answer
- FDA Approval, Eligibility, and Why Insurers Cover Esketamine
- Spravato Prior Authorization: What Insurers Require Before They Say Yes
- How to Get Spravato Approved by Insurance: A Step-by-Step Checklist
- Esketamine Cost With Insurance: Copays, Coinsurance, and What You'll Pay
- Spravato Coverage Appeal: What to Do When Your Insurer Denies Treatment
- How Coverage Differs by Plan Type and Between Esketamine and IV Ketamine
- Frequently Asked Questions
Last Updated: October 5, 2026
Is Esketamine Treatment Covered by Insurance? The Short Answer
Yes, esketamine treatment covered by insurance is often possible, but approval is not automatic. Most commercial plans cover Spravato, the FDA-approved esketamine nasal spray, when it is prescribed for treatment-resistant depression and when the plan's rules are met. At Trust and Care Mental Health Inc, we help patients in Fairfield and Bridgeport work through those rules every week.
The catch is that "covered" rarely means "no cost." Coverage depends on your plan, your diagnosis, and whether your provider completes prior authorization correctly. Below, we explain how insurers decide, what you will likely pay, and how to appeal a denial.
Esketamine treatment is a supervised therapy using esketamine, a form of ketamine delivered as a nasal spray, for adults with depression that has not improved after other treatments.
FDA Approval, Eligibility, and Why Insurers Cover Esketamine
Insurers cover esketamine because the FDA approved it for a specific, well-defined use. Spravato received FDA approval for treatment-resistant depression in adults, and later for depressive symptoms in adults with major depressive disorder who have suicidal thoughts or actions.
That approval matters for coverage. Plans generally follow FDA labeling when deciding what is medically necessary.
To qualify, patients usually must:
- Have a diagnosis of treatment-resistant depression or major depressive disorder
- Have tried and failed at least two antidepressant medications
- Be an adult, since the nasal spray is approved for adults
- Use it alongside an oral antidepressant, not on its own
The FDA prescribing information for Spravato spells out these approved uses. Your doctor documents how you meet them.
Spravato Prior Authorization: What Insurers Require Before They Say Yes
Spravato prior authorization is the review your insurer runs before agreeing to pay. It is the single biggest gatekeeper for coverage.
Most insurers want the same core items:
- Your diagnosis and symptom history
- A list of antidepressants you have tried, with doses and dates
- A note that at least two failed
- A treatment plan from your prescribing provider
- Confirmation the drug will be given under supervision
Some plans also require you to try a generic oral antidepressant first. Others limit coverage to in-network providers.
How to Get Spravato Approved by Insurance: A Step-by-Step Checklist
Most guides tell you to "call your insurer." That is not enough. Approval usually turns on whether your provider submits the right documentation with the right codes the first time. Use this checklist before your first dose is scheduled.
Before you call: gather these documents
- Your insurance card (medical and pharmacy benefit numbers, if separate)
- The plan's Summary of Benefits and Coverage and its drug formulary
- Your antidepressant history: drug name, dose, start date, stop date, and reason for stopping (side effects count)
- Your diagnosis code from your provider (commonly F33.1 or F33.2 for recurrent major depressive disorder, and F32.x for single episodes)
- Your provider's NPI and tax ID, plus the clinic's address where the drug will be administered
Questions to ask your insurer, word for word
- "Is Spravato (esketamine) on my plan's formulary, and what tier is it on?"
- "Does it require prior authorization, and what is the exact criteria list?"
- "Is the drug billed under my pharmacy benefit or my medical benefit?"
- "Is the administering clinic in-network for both the drug and the observation visit?"
- "What is my copay, coinsurance, and deductible status for each component?"
- "Is a site-of-care restriction in place, meaning must I receive it at a specific facility type?"
- "What is the reference number for this call, and can you mail or email the written criteria?"
Billing codes your provider will likely use
Esketamine visits generate more than one line on a claim. Knowing the codes helps you catch errors and ask better questions.
- J3490 or the specific HCPCS code for esketamine, the drug itself
- 99213 or 99214, the evaluation and management portion of the visit
- 96372, injection or supervised administration, when applicable
- G-codes or 99xxx series codes, observation and monitoring time, depending on the payer
Exact codes vary by payer and by how the visit is structured. Ask your provider's billing office which codes they plan to submit, then read those codes back to your insurer.
What to do if the answer is "not covered"
- Ask whether the denial is a benefit exclusion (the plan simply does not cover the drug) or a medical necessity denial (the plan covers it but does not think you qualify). The two have very different appeal paths.
- If it is a benefit exclusion, ask about an exception-to-formulary request or a formulary tier exception.
- If it is a medical necessity denial, request the written criteria and compare it line by line to your chart notes.
- Ask your provider to submit a letter of medical necessity that quotes the FDA label and your documented treatment failures.
Esketamine Cost With Insurance: Copays, Coinsurance, and What You'll Pay
Esketamine cost with insurance is not one number. A single treatment visit can generate four separate charges, and each one runs through a different part of your benefits. Understanding that structure is the difference between a $40 visit and a $400 one.
| Charge Type | What It Covers | How It's Billed |
|---|---|---|
| Medication | The Spravato nasal spray | Prescription drug benefit (pharmacy) |
| Administration | The supervised dosing visit | Medical benefit |
| Monitoring | Blood pressure checks and observation time (typically two hours) | Medical benefit |
| Facility | The treatment room, staff, and equipment | Medical benefit |
Why the same drug can cost two patients very different amounts
- Pharmacy vs. medical benefit. If the drug runs through your pharmacy benefit, you may pay a specialty-tier copay. If it runs through your medical benefit, you may pay coinsurance on the drug's allowed amount instead.
- Deductible status. Early in the year, you may owe the full allowed amount until your deductible is met. Later in the year, you may owe only coinsurance.
- In-network vs. out-of-network. Out-of-network rates can double or triple your share, and some plans do not cover out-of-network esketamine at all.
- Induction vs. maintenance. Induction typically involves two visits per week for the first four weeks, then weekly maintenance. Visit frequency drives total cost more than any single charge.
A realistic cost-estimation worksheet
Work through these steps with your plan documents in hand. Do not guess, pull the actual numbers from your Summary of Benefits and Coverage.
- Find your deductible. How much is left before it is met?
- Find your coinsurance rate. Common rates are 20%, 30%, or 40% for specialty drugs and outpatient visits.
- Find your copay for specialty-tier drugs. This may apply instead of coinsurance for the drug portion.
- Find your out-of-pocket maximum. Once you hit it, most plans cover covered services at 100% for the rest of the plan year.
- Estimate visit count. A common induction schedule is eight visits over four weeks, followed by weekly maintenance.
- Multiply. (Per-visit patient share) × (visits per month) = your monthly out-of-pocket estimate.
- Compare to your out-of-pocket maximum. If your estimate exceeds it, your true annual cost is capped at that number.
A worked example (illustrative only)
Suppose your plan has a $1,500 deductible you have not met, 20% coinsurance on outpatient visits, a $100 specialty-drug copay, and a $6,000 out-of-pocket maximum. During induction at two visits per week, your monthly patient share could plausibly land in the high hundreds to low thousands of dollars until your deductible is met, then drop to coinsurance plus the drug copay. Once you reach the out-of-pocket maximum, most plans cover the rest of the year.
Actual figures depend entirely on your plan. Use the worksheet above with your own numbers rather than this example.
Questions that shrink the bill
- "Is the drug billed under my pharmacy or medical benefit?"
- "Is there a lower-cost site of care I am required to use?"
- "Does the manufacturer offer a copay assistance program, and does my plan allow it to count toward my deductible?"
- "Are there financial assistance programs through the clinic or a patient support program?"
Because plans vary so much, we cannot quote a price. For current figures, check with Trust and Care Mental Health Inc directly or call your insurer and ask for the allowed amount under your specific plan.
Spravato Coverage Appeal: What to Do When Your Insurer Denies Treatment
A Spravato coverage appeal is your next step after a denial, and it often works. Many denials are about process, not medicine.
Here is what to do:
- Read the denial letter and find the exact reason
- Ask your provider to send the missing records
- Request a peer-to-peer review between your doctor and the insurer's reviewer
- File a formal appeal within the plan's deadline
- Ask about a patient support program for help
The U.S. Department of Labor rules on appealing health plan denials explain your right to an internal appeal and, in many cases, an external review.
How Coverage Differs by Plan Type and Between Esketamine and IV Ketamine
Coverage is not the same across plans, and it is not the same for every form of ketamine. This is where a lot of confusion starts.
- Commercial insurance: Often covers Spravato with prior authorization
- Medicare: May cover it under Part B or Part D, depending on how it is given
- Medicaid and managed Medicaid: Coverage varies by state
- IV ketamine: Frequently not covered, because it is not FDA-approved for depression
That last point surprises people. The FDA drug approval information shows esketamine as approved for depression, while IV ketamine is not. Insurers follow that difference closely.
At Trust and Care Mental Health Inc, we offer treatment-only options for referring providers, so your care team stays involved.
Frequently Asked Questions
How much does esketamine cost with insurance?
What you pay depends on your deductible, copay, and coinsurance. Many commercial plans place Spravato on a specialty tier, so a percentage of the medication cost applies until you reach your out-of-pocket maximum. Medicare and managed Medicaid plans may have different rules. Because pricing varies by plan, ask your insurer for a written estimate and request a benefits check before your first appointment so you know your expected patient responsibility.
Does insurance cover Spravato for treatment-resistant depression?
Many commercial insurance carriers, Medicare, and managed Medicaid plans cover Spravato when it is prescribed for treatment-resistant depression and the patient meets the plan's coverage criteria. Coverage is not automatic. Most plans require prior authorization, documentation that you have tried at least two antidepressants without relief, and treatment in a certified setting with supervised administration and clinical monitoring. Coverage for other uses is less common.
What should I do if my insurance denies Spravato coverage?
Read the denial letter carefully to see the stated reason, then file a formal appeal within the deadline your plan lists. Ask your prescribing provider to submit a letter of medical necessity with your treatment history and diagnosis. You can also request a peer-to-peer review between your provider and the insurer's reviewer. If the first appeal fails, most plans allow a second-level appeal. Patient support programs and financial assistance may help while you wait.
Does insurance cover the medication and the clinic visits separately?
Often, yes. Esketamine treatment can generate separate charges for the medication itself, the administration by a healthcare professional, clinical monitoring during and after each session, and the facility fee. Your prescription drug coverage may handle the medication while your medical benefits handle the administration and monitoring. Ask your insurer which benefit applies to each line item so you can avoid billing surprises and understand your total out-of-pocket cost.
Depression that has not responded to treatment is exhausting, and the insurance maze makes it worse. Trust and Care Mental Health Inc offers FDA-approved Spravato esketamine nasal spray in a monitored clinical setting, with a team that supports children, adults, and older adults. We handle prior authorization and appeals, and we offer treatment-only options for referring providers. Make your appointment today and let us help you find a path forward.
